Lara Tape Labs - designing, manufacturing and marketing proven expanded polytetrafluoroethylene ePTFE and PTFE products to the wire and cable, textile, industrial, automotive, robotics, and medical device industries
Milholland & Associates is internationally recognized for their expertise in HEPA / ULPA filter testing and cleanroom contamination control in the semiconductor, aerospace, and pharmaceutical industries.
Certified manufacturer of ePTFE sheets, rods and melt thermoplastic custom tubes, rods and profiles using the latest in polymer technology and automated extrusion techniques.
Gaskets Materials and Seal Sheet Online Shop from USA. Gasketing and Seal Sales for gasket material,gasket sheet, non-asbestos gasketing,sheet packing,eptfe sheet,aflas gasket material,FKM gasket material,Viton Gasketing,Silicone Gasketing, Mica Gasketing
Herstellung von: Kammprofilfichtungen,Spiraldichtungen, RTJ Dichtungen,Flachdichtungen aus Graphit,Aramidfaser,PTFE,Gummi. Dichtungsbänder aus ePTFE,Packungen,Dichtungsplatten, Dichtungen nach TA-Luft
Artegraft has been in continuous clinical use since 1970. The first vascular graft approved by the FDA, it has clinically proven higher primary and assisted patency rates over ePTFE grafts.
Artegraft has been in continuous clinical use since 1970. The first vascular graft approved by the FDA, it has clinically proven higher primary and assisted patency rates over ePTFE grafts.
BARD Peripheral Vascular OEM is a medical textile manufacturer that provides the following implantable materials: cardiovascular fabrics,
implantable textiles, surgical felts, tubular fabrics, guidewires, ePTFE custom capabilities, and custom capabiliti
Artegraft has been in continuous clinical use since 1970. The first vascular graft approved by the FDA, it has clinically proven higher primary and assisted patency rates over ePTFE grafts.
Artegraft has been in continuous clinical use since 1970. The first vascular graft approved by the FDA, it has clinically proven higher primary and assisted patency rates over ePTFE grafts.
Artegraft has been in continuous clinical use since 1970. The first vascular graft approved by the FDA, it has clinically proven higher primary and assisted patency rates over ePTFE grafts.
Artegraft has been in continuous clinical use since 1970. The first vascular graft approved by the FDA, it has clinically proven higher primary and assisted patency rates over ePTFE grafts.
Artegraft has been in continuous clinical use since 1970. The first vascular graft approved by the FDA, it has clinically proven higher primary and assisted patency rates over ePTFE grafts.
Artegraft has been in continuous clinical use since 1970. The first vascular graft approved by the FDA, it has clinically proven higher primary and assisted patency rates over ePTFE grafts.
Artegraft has been in continuous clinical use since 1970. The first vascular graft approved by the FDA, it has clinically proven higher primary and assisted patency rates over ePTFE grafts.
Artegraft has been in continuous clinical use since 1970. The first vascular graft approved by the FDA, it has clinically proven higher primary and assisted patency rates over ePTFE grafts.